Post 1 to 1 of 1

From copycat to innovation hub: the evolving landscape of biotech in Asia

Varshit Dusad Building a biotech enterprise is hard. Huge costs, high development time, tight regulations, funding crunches and failure to build a viable product are some of the factors that can deal a death blow. And yet, starting a biotech enterprise is even harder in emerging economies as there is a lack of scientific know-how, and risk-averse investors, which are often coupled with… Read more